Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Primary sarcomatoid carcinoma...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Primary sarcomatoid carcinoma of the ileum: Genetic alterations and treatment

Primary sarcomatoid carcinoma of the ileum: Genetic alterations and treatment

Bibliographic Details
Main Authors: Yan Zhang, Wei Gao, Feng Cao
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:Asian Journal of Surgery
Subjects:
Ileum sarcomatoid carcinoma
Immunotherapy
Tyrosine kinase inhibitors
Online Access:http://www.sciencedirect.com/science/article/pii/S1015958422007308
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S1015958422007308

Similar Items

  • Comparison of tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma with rhabdoid and sarcomatoid differentiations
    by: Kun Wang, et al.
    Published: (2023-07-01)
  • Research progress in precision treatment of pulmonary sarcomatoid carcinoma
    by: GAO Zhilan, et al.
    Published: (2023-12-01)
  • Primary Liver Sarcomatoid Carcinoma: A Case Series and Literature Review
    by: Ji W, et al.
    Published: (2021-09-01)
  • Treatment and Outcome of Metastatic Renal Cell Carcinoma With Sarcomatoid Differentiation: A Single-Center, Real-World Analysis of Retrospective Data
    by: Florian Janisch, et al.
    Published: (2021-11-01)
  • Case report: Significant benefits of tislelizumab combined with anlotinib in first-line treatment of metastatic renal pelvic urothelial carcinoma with sarcomatoid carcinoma differentiation
    by: Shibin Zhu, et al.
    Published: (2022-10-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs